BioPlus Acquisition Corp. BIOS Stock
10.8 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Financial Services
INDUSTRY
Shell Companies
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
209.07M USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
BioPlus Acquisition Corp. Price Chart
BioPlus Acquisition Corp. BIOS Financial and Trading Overview
| BioPlus Acquisition Corp. stock price | 10.8 USD |
| Previous Close | 10.56 USD |
| Open | 10.6 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 1000 |
| Day's Range | 10.56 - 10.7 USD |
| 52 Week Range | 9.91 - 11.24 USD |
| Volume | 30.26K USD |
| Avg. Volume | 173.22K USD |
| Market Cap | 309.81M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 66.0625 |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 USD |
BIOS Valuation Measures
| Enterprise Value | 314.95M USD |
| Trailing P/E | 66.0625 |
| Forward P/E | 33.03125 |
| PEG Ratio (5 yr expected) | -7.93 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioPlus Acquisition Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 6.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.24 USD |
| 52 Week Low | 9.91 USD |
| 50-Day Moving Average | 10.51 USD |
| 200-Day Moving Average | 10.29 USD |
BIOS Share Statistics
| Avg. Volume (3 month) | 173.22K USD |
| Avg. Daily Volume (10-Days) | 37.31K USD |
| Shares Outstanding | 29.31M |
| Float | 23.56M |
| Short Ratio | 0.01 |
| % Held by Insiders | 3.73% |
| % Held by Institutions | 91.73% |
| Shares Short | 1.97K |
| Short % of Float | 0.010% |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -0.29% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 4.58M USD |
| Diluted EPS (ttm) | 0.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.37K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 5.47M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.638 |
| Book Value Per Share (mrq) | -0.514 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -840581 USD |
| Levered Free Cash Flow (ttm) | -759322 USD |
Profile of BioPlus Acquisition Corp.
| Country | United States |
| State | NY |
| City | New York |
| Address | 260 Madison Avenue |
| ZIP | 10026 |
| Phone | 212 287 4092 |
| Website | https://bioplusspac.com |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | N/A |
BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Q&A For BioPlus Acquisition Corp. Stock
What is a current BIOS stock price?
BioPlus Acquisition Corp. BIOS stock price today per share is 10.8 USD.
How to purchase BioPlus Acquisition Corp. stock?
You can buy BIOS shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioPlus Acquisition Corp.?
The stock symbol or ticker of BioPlus Acquisition Corp. is BIOS.
Which industry does the BioPlus Acquisition Corp. company belong to?
The BioPlus Acquisition Corp. industry is Shell Companies.
How many shares does BioPlus Acquisition Corp. have in circulation?
The max supply of BioPlus Acquisition Corp. shares is 19.37M.
What is BioPlus Acquisition Corp. Price to Earnings Ratio (PE Ratio)?
BioPlus Acquisition Corp. PE Ratio is 0.00000000 now.
What was BioPlus Acquisition Corp. earnings per share over the trailing 12 months (TTM)?
BioPlus Acquisition Corp. EPS is 0 USD over the trailing 12 months.
Which sector does the BioPlus Acquisition Corp. company belong to?
The BioPlus Acquisition Corp. sector is Financial Services.
BioPlus Acquisition Corp. BIOS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
- {{ link.label }} {{link}}